AIBN Ernst Wolvetang receiving his Aon Risk Solutions Regenerative Medicine Award - Shaun Murray Photography
AIBN Ernst Wolvetang receiving his Aon Risk Solutions Regenerative Medicine Award - Shaun Murray Photography
A regenerative medicine researcher from The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN), has been celebrated for enhancing the potential of this growing field within life sciences.

Associate Professor Ernst Wolvetang has received the Aon Risk Solutions Regenerative Medicine Award from Life Sciences Queensland Limited (LSQ).

LSQ presented four awards at its annual ‘Globally Engaging Networking Event (GENE)’ on Friday 17 October, to recognise and celebrate individuals who have contributed significantly to the establishment and growth of the Queensland life sciences industry.

“Associate Professor Ernst Wolvetang, received the Aon Risk Solutions Regenerative Medicine Award, for his initiative, dedication and leadership in the area of regenerative medicine, particularly as a pioneer in stem cell research,” LSQ CEO Mr Mario Pennisi said.

In receiving his award, Ernst made a point of acknowledging all the people he works with at AIBN, who make his work possible, and said that the award was just as much for them as it was for himself.

He further congratulated Aon in supporting this exciting area of research and pointed out the great opportunities for Queensland to take the lead in regenerative medicine through effective multi-institutional collaborations and support of the emerging regenerative medicine industry.

Along with the recognition of these individuals, GENE provided the opportunity for life sciences industry leaders, elected officials and other interested stakeholders to come together for an evening of networking and celebration of the industry’s achievements.

Media Contact: Ruth Neale, +61 7 3346 3965,

About Life Sciences Queensland Limited
LSQ is an industry organisation working closely with its Members and the broader industry to provide leadership, networking and growth opportunities for life sciences firms in Australia, and enhance Members’ national and international reputations as providers of commercial and research excellence in the life sciences.
LSQ press release

Aon Risk Solutions Regenerative Medicine Award
The RMA aims to recognise work by individuals from LSQ Member entities in the area of regenerative medicine. It will assist with broadening objectives, outcomes and opportunities within the regenerative medicine industry through the provision of finances and recognition among the media, domestic and international business leaders, investors and the community. The award will also help highlight Queensland’s life sciences profile to a globally diverse audience. The winner of the award receives AU$2000 in cash.

About Aon
Aon plc (NYSE:AON) is the leading global provider of risk management, insurance and reinsurance brokerage, and human resources solutions and outsourcing services. Through its more than 66,000 colleagues worldwide, Aon unites to empower results for clients in over 120 countries via innovative and effective risk and people solutions and through industry-leading global resources and technical expertise. Aon has been named repeatedly as the world’s best broker, best insurance intermediary, best reinsurance intermediary, best captives manager, and best employee benefits consulting firm by multiple industry sources. Visit for more information on Aon and to learn about Aon’s global partnership with Manchester United.

On this site

Go to top